Biological Wastewater Treatment Systems for the Biodegradation and Detoxification of Pharmaceuticals

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60076658%3A12520%2F24%3A43908053" target="_blank" >RIV/60076658:12520/24:43908053 - isvavai.cz</a>

Výsledek na webu

<a href="https://www.taylorfrancis.com/chapters/edit/10.1201/9781003436607-4/biological-wastewater-treatment-systems-biodegradation-detoxification-pharmaceuticals-begum-yurdakok-dikmen-nikola-tresnakova-ayhan-filazi-caterina-faggio" target="_blank" >https://www.taylorfrancis.com/chapters/edit/10.1201/9781003436607-4/biological-wastewater-treatment-systems-biodegradation-detoxification-pharmaceuticals-begum-yurdakok-dikmen-nikola-tresnakova-ayhan-filazi-caterina-faggio</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1201/9781003436607-4" target="_blank" >10.1201/9781003436607-4</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Biological Wastewater Treatment Systems for the Biodegradation and Detoxification of Pharmaceuticals

Popis výsledku v původním jazyce

The presence of human and veterinary pharmaceuticals in the form of the unmetabolized parent compound, metabolite or other transformed products, and drug manufacturing products in the aquatic surroundings is a growing global concern. These pharmaceutical micropollutants discharged from treated and untreated wastewater treatment plants can be transferred to the sludge to a significant extent. Residues of several pharma-active compounds, such as antibiotics, anti-inflammatory/analgesic/antipyretics, antineoplastics/cancer drugs, neuroactives (antiepileptics, antidepressants, anxiolytics), cardiovascular drugs (β-blocker, antilipidemic), diuretics, hormones, and others are found in aquatic organisms in varying concentrations. As these micropollutants cover a broad range of complex structured compounds, their range of removal through sorption and biotic or abiotic degradation differs depending on the chemical and the environmental matrix along with other factors such as organic matter content and water chemistry. Abiotic degradation occurs through natural and introduced processes, including photolysis, hydrolysis, volatilization, ultrasound processing, membrane filtration, and nanomaterials, while in bioconversion, selected strains of microorganisms (bacterial yeast and fungi) are used to produce metabolites. This chapter presents detailed information on sources and types of the most used pharmaceuticals, factors influencing the biodegradation of pharmaceuticals, and biologic degradation procedures in wastewater treatment plants.

Název v anglickém jazyce

Biological Wastewater Treatment Systems for the Biodegradation and Detoxification of Pharmaceuticals

Popis výsledku anglicky

The presence of human and veterinary pharmaceuticals in the form of the unmetabolized parent compound, metabolite or other transformed products, and drug manufacturing products in the aquatic surroundings is a growing global concern. These pharmaceutical micropollutants discharged from treated and untreated wastewater treatment plants can be transferred to the sludge to a significant extent. Residues of several pharma-active compounds, such as antibiotics, anti-inflammatory/analgesic/antipyretics, antineoplastics/cancer drugs, neuroactives (antiepileptics, antidepressants, anxiolytics), cardiovascular drugs (β-blocker, antilipidemic), diuretics, hormones, and others are found in aquatic organisms in varying concentrations. As these micropollutants cover a broad range of complex structured compounds, their range of removal through sorption and biotic or abiotic degradation differs depending on the chemical and the environmental matrix along with other factors such as organic matter content and water chemistry. Abiotic degradation occurs through natural and introduced processes, including photolysis, hydrolysis, volatilization, ultrasound processing, membrane filtration, and nanomaterials, while in bioconversion, selected strains of microorganisms (bacterial yeast and fungi) are used to produce metabolites. This chapter presents detailed information on sources and types of the most used pharmaceuticals, factors influencing the biodegradation of pharmaceuticals, and biologic degradation procedures in wastewater treatment plants.

Druh

C - Kapitola v odborné knize

CEP obor

—

OECD FORD obor

10511 - Environmental sciences (social aspects to be 5.7)

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název knihy nebo sborníku

Pharmaceuticals in Aquatic Environments. Remediation Technologies and Future Challenges.

ISBN

978-1-03-255763-2

Počet stran výsledku

22

Strana od-do

65-86

Počet stran knihy

291

Název nakladatele

CRC Press

Místo vydání

Boca raton

Kód UT WoS kapitoly

—